EMA — authorised 11 January 2022
- Marketing authorisation holder: Vifor Fresenius Medical Care Renal Pharma France
- Status: approved
🇪🇺 Tavneos in European Union
EMA authorised Tavneos on 11 January 2022
Marketing authorisation
Tavneos in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in European Union
Frequently asked questions
Is Tavneos approved in European Union?
Yes. EMA authorised it on 11 January 2022.
Who is the marketing authorisation holder for Tavneos in European Union?
Vifor Fresenius Medical Care Renal Pharma France holds the EU marketing authorisation.